Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Medical Journal ; (24): 172-176, 2011.
Artigo em Inglês | WPRIM | ID: wpr-321475

RESUMO

<p><b>BACKGROUND</b>Both repaglinide and gliclazide are insulin secretagogues widely used in the treatment of type 2 diabetes. They stimulate insulin secretion through distinct mechanisms and may benefit patients from different aspects. The present study was to evaluate the effects of repaglinide or gliclazide on glycaemic control, insulin secretion, and lipid profiles in type 2 diabetes patients.</p><p><b>METHODS</b>A total of 47 newly diagnosed type 2 diabetes patients were randomized 1:1 to receive a 4-week treatment with repaglinide or gliclazide. The standard mixed meal tolerance test was performed before and after the treatment. Plasma glucose (PG), insulin concentration, and lipid profiles were measured. The area under insulin concentration curve (AUC(ins)) and the early-phase insulin secretion index (ΔI(30)/ΔG(30)) were calculated.</p><p><b>RESULTS</b>After the trial, fasting and postprandial PG and postprandial insulin improved significantly in both groups (P < 0.05). The maximum insulin concentration occurred earlier in the repaglinide group than that in the gliclazide group. AUC(ins) increased in both groups (P < 0.05), but no significant difference was found between groups. ΔI(30)/ΔG(30) increased in both groups (P < 0.05), especially in the repaglinide group (P < 0.05). Triglyceride and total cholesterol decreased significantly in the repaglinide group in some time points, while no significant change was observed in the gliclazide group.</p><p><b>CONCLUSIONS</b>Repaglinide and gliclazide had similar effects on glycaemic control and total insulin secretion, while repaglinide had more effects on improvements in β-cell function and lipid metabolism.</p>


Assuntos
Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Glicemia , Carbamatos , Usos Terapêuticos , Colesterol , Sangue , Diabetes Mellitus Tipo 2 , Sangue , Tratamento Farmacológico , Metabolismo , Jejum , Sangue , Gliclazida , Usos Terapêuticos , Hipoglicemiantes , Usos Terapêuticos , Insulina , Secreções Corporais , Piperidinas , Usos Terapêuticos , Período Pós-Prandial , Resultado do Tratamento , Triglicerídeos , Sangue
2.
Journal of Central South University(Medical Sciences) ; (12): 238-244, 2008.
Artigo em Chinês | WPRIM | ID: wpr-814089

RESUMO

OBJECTIVE@#To determine the effect of different concentrations of glucose on the differentiation of 3T3-L(1) and the expression of insig-1 and insig-2 mRNA, and to explore the effect of insulin-induced gene in the differentiation and formation of adipocytes and lipogenesis.@*METHODS@#The 3T3-L(1) cells were induced to differentiate in high glucose concentration (25 mol/L G.S), low glucose concentration (5.5 mol/L G.S), and mannitol (19.5 mol/L Mannitol +5.5 mol/L G.S), respectively. The differentiation of 3T3-L(1) cells was examined by oil red "O" straining, and the expression of insig-1,insig-2 mRNA and AP2 mRNA was examined by RT-PCR and in situ hybridization.@*RESULTS@#With the differentiation of 3T3-L(1) cells, the expression of insig-1 and insig-2 mRNA was gradually up-regulated. The expression of insig-1 and insig-2 mRNA significantly increased while AP(2) mRNA decreased in the low glucose concentration inducing group and mannitol inducing group. In the high glucose concentration inducing group, the cell differentiation was poor (P<0.05). There was no difference between the low glucose concentration and the mannitol group in the differentiation of 3T3-L(1) cells, and in the expression of insig-1 and insig-2 and AP(2) mRNA.@*CONCLUSION@#Different concentrations of glucose may influence the cell differentiation and the low glucose concentration promotes insig-1 and insig-2 gene expression, which may lead to the inhibition of the differentiation and lipogenesis of preadipocytes.


Assuntos
Animais , Camundongos , Células 3T3-L1 , Diferenciação Celular , Relação Dose-Resposta a Droga , Glucose , Farmacologia , Proteínas de Membrana , Genética , RNA Mensageiro , Genética
3.
Journal of Central South University(Medical Sciences) ; (12): 36-40, 2007.
Artigo em Chinês | WPRIM | ID: wpr-813940

RESUMO

OBJECTIVE@#To evaluate the expression of hCTLA4-Ig and their biological function in newborn porcine islets (NPIs) transfected with AAV-hCTLA4-Ig.@*METHODS@#Cultured NPIs were transfected with AAV-hCTLA4-Ig. The expression of CTLA4-Ig in these NPIs was assayed by RT-PCR and immunocytochemistry. The levels of IL-2, IFN-gamma, and TNF-alpha in the culture medium were assayed by ELISA after these cells the co-cultured with human. The response of glucose-stimulated insulin secretion was observed in the transgene group and the control group.@*RESULTS@#The expressions of CTLA4-Ig mRNA and protein were detected in the transgene group. The levels of cytokines were obviously lower in the transgene group than those in the control group (P0.05).@*CONCLUSION@#AAV mediated hCTLA4-Ig expression in NPIs could inhibit T lymphocyte to produce cytokines, while the endocrine functions of the NPIs were not significantly affected.


Assuntos
Animais , Humanos , Animais Recém-Nascidos , Antígenos CD , Genética , Antígenos de Diferenciação , Genética , Antígeno CTLA-4 , Células Cultivadas , Dependovirus , Genética , Ensaio de Imunoadsorção Enzimática , Expressão Gênica , Fragmentos Fc das Imunoglobulinas , Genética , Imuno-Histoquímica , Interferon gama , Interleucina-2 , Ilhotas Pancreáticas , Biologia Celular , Alergia e Imunologia , Metabolismo , Proteínas Recombinantes de Fusão , Genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Suínos , Transfecção , Fator de Necrose Tumoral alfa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA